{"url_path":"/sec/anip/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","accession_number":"0001023024-26-000050","cik":"0001023024","ticker":"ANIP","issuer_name":"ANI PHARMACEUTICALS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1023024/0001023024-26-000050-index.html","primary_entity_key":"0001023024","primary_entity_name":"ANI PHARMACEUTICALS INC"},"word_count":260,"has_tables":true,"body_markdown":"Item 6.    Exhibits\n\nThe exhibits listed in the Index to Exhibits, which is incorporated herein by reference, are filed or furnished as part of this Quarterly Report on Form 10-Q.\n\nINDEX TO EXHIBITS\n\nExhibit No.Description\n\n31.1\n[Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, Rule 13(a)-14(a)/15d-14(a).](anip-20260331x10qxexx311.htm)\n\n31.2\n[Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, Rule 13(a)-14(a)/15d-14(a).](anip-20260331x10qxexx312.htm)\n\n32.1*\n[Certification of Chief Executive Officer and Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](anip-20260331x10qxexx321.htm)\n\n101.INSInline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the inline XBRL document.\n\n101.SCHInline XBRL Taxonomy Extension Schema Document\n\n101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n101.LABInline XBRL Taxonomy Extension Label Linkbase Document\n\n101.PREInline XBRL Taxonomy Extension Presentation Linkbase\n\n101.DEFInline XBRL Taxonomy Extension Definition Linkbase\n\n104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n* In accordance with SEC Release 33-8238, Exhibit 32.1 is being furnished and not filed.\n\n43\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nANI Pharmaceuticals, Inc. (Registrant)\n\nDate:May 8, 2026By:/s/ Nikhil Lalwani\n\nNikhil Lalwani\n\nPresident and\n\nChief Executive Officer\n\n(principal executive officer)\n\nDate:May 8, 2026By:/s/ Stephen P. Carey\n\nStephen P. Carey\n\nSenior Vice President, Finance and\n\nChief Financial Officer\n\n(principal financial and accounting officer)\n\n44"}